METHOD FOR SCREENING PRO- OR ANTIAPOPTOGENOUS ACTIVITY OF THERAPEUTIC PREPARATIONS Russian patent published in 2010 - IPC G09B23/28 

Abstract RU 2388065 C1

FIELD: medicine.

SUBSTANCE: invention refers to medicine and pharmacology and can be used for studying the influence of therapeutic preparations on apoptosis. The method is implemented as follows: Newborn infant rats aged 2-8 days are divided on two groups (reference and experience). To experimental infant rats, a studied preparation is introduced subcutaneously in a therapeutic dose, and the reference animals get an equivalent amount of physiologic saline. 6-120 hours later, the animals of both groups are decapitated to separate posterior and (or) cortical cerebrum; thereafter cerebral tissue is analysed by any available methods to evaluate the apoptosis intensity. The varying intensity of natural apoptosis in cerebral structures of the experimental infant rats in 2 times and more times in comparison with the reference animals ensures to observe pro- or antiapoptogenous activity of a studied preparation.

EFFECT: method allows improving accuracy and reliability of screening the preparations with estimated pro- or antiapoptogenous activity.

2 cl, 2 dwg, 2 ex

Similar patents RU2388065C1

Title Year Author Number
APPLICATION OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINES IN DEMENTIA AND PARKINSON'S DISEASE TREATMENT 2003
  • Tatton Vil'Jam G.
  • Viler Larri A.
  • Dzhil Dehniehl V.
  • Donello Dzhon E.
RU2332218C2
AGENT WITH ANTIAPOPTOTIC ACTIVITY 2018
  • Kampe-Nemm Elena Arturovna
  • Kolobov Aleksandr Aleksandrovich
  • Rogovskaya Nadezhda Yurevna
  • Babakov Vladimir Nikolaevich
RU2685428C1
APOPTOSIS INHIBITORS AND USE THEREOF 2011
  • Barrer Stefani
  • Narzho Zhoel
  • Leble Bernar
  • Buageren Priska
  • Po Kristof
RU2582247C2
CARDIOTROFIN APPLICATION IN LIVER DISEASES 2002
  • Bustos De Abakho Matil'De
  • Prieto Valtuehn'Ja Khesus
  • Lasarte Sagastibel'Sa Khuan Khose
  • Bajkseras L'Jano Ehlena
RU2279289C2
ESTROGEN COMPONENTS FOR APPLICATION IN NEUROLOGICAL DISORDERS TREATMENT 2013
  • Fuadar Zhan-Mishel
  • Tskitishvili Ekaterin
RU2627846C2
METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS 2003
  • Shebitts Vol'F-Rjudiger
  • Shnajder Armin
  • Krjuger Karola
  • Zommer Klemens
  • Shvab Shtefan
  • Koll'Mar Rajner
  • Maurer Martin
  • Veber Daniehla
  • Gassler Nikolaus
RU2353385C2
METHOD FOR ASSESSING COPPER NANOPARTICLES ADMINISTRATION SAFETY 2011
  • Sizova Elena Anatol'Evna
  • Miroshnikov Sergej Aleksandrovich
  • Poljakova Valentina Sergeevna
  • Glushchenko Natal'Ja Nikolaevna
RU2477485C2
PROAPOPTOSIS PROTEINS-CONTAINING THERAPEUTIC AGENTS 2002
  • Rozenbljum Majkl G.
  • Liu Jujing
RU2319709C2
CDP-CHOLINE - PROPHYLACTIC AGENT FOR TREATMENT OF CEREBRAL ISCHEMIA AND METHOD FOR TREATMENT WITH ITS USING 2001
  • Kastello Khosep M.
  • Losano Rafaehl'
  • Ortis Khose A.
  • Raga Manuehl'
  • Ramentol' Khorkhe
  • Sekades Khulio Kh.
  • Ferrer Isidro Kh.
  • Foget Rafaehl'
RU2255741C2
METHOD FOR IDENTIFYING COMPOUNDS FOR TREATING CANCER 2010
  • Soehngas Gonsales Marija Soledad
  • Tormo Karul'Ja Damija
RU2575828C2

RU 2 388 065 C1

Authors

Dygalo Nikolaj Nikolaevich

Kalinina Tat'Jana Sergeevna

Shishkina Galina Trifonovna

Dates

2010-04-27Published

2008-12-08Filed